GAMCO Investors’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-45,050
Closed -$682K 930
2022
Q3
$682K Buy
+45,050
New +$524K 0.01% 635

GAMCO Investors's AERI Position: Q4 2022 in Review

GAMCO Investors sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 45,050 shares — an estimated $682K sold.

GAMCO Investors first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $682K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • GAMCO Investors reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • GAMCO Investors sold 45,050 Aerie Pharmaceuticals shares in Q4 2022, an estimated $682K.
  • GAMCO Investors first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • GAMCO Investors's Aerie Pharmaceuticals position peaked at $682K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on GAMCO Investors's 13F filing for Q4 2022, filed 13 Feb 2023.